6th November 2017

U.S. Volleyball Athlete Alexandra Klineman Accepts Finding of No Fault for ADRV

USADA announced today that Alexandra Klineman, of Manhattan Beach, Calif., an athlete in the sport of volleyball, has tested positive for prohibited substances, which were determined to have been ingested by her without fault or negligence. Klineman, 27, tested positive for hydrochlorothiazide and triamterene as the result of an out-of-competition urine sample she provided on July 25, 2017. Hydrochlorothiazide and triamterene are both Specified Substances in the class of Diuretics and Masking Agents and prohibited at all times under the USADA Protocol for Olympic and Paralympic Movement Testing, the United States Olympic Committee National Anti-Doping Policies, and the Fédération Internationale de Volleyball Anti-Doping Rules, all of which have adopted the World Anti-Doping Code and the World Anti-Doping Agency Prohibited List.

During USADA’s investigation into the circumstances of her case, Klineman provided USADA with records for a permitted oral prescription medication she was taking at the time of her positive test. This permitted medication did not list hydrochlorothiazide and triamterene on the label, which are available only by prescription, or any other prohibited substances. However, detailed laboratory analyses subsequently conducted on the medication tablets confirmed hydrochlorothiazide and triamterene contamination. As a result, Klineman will not face a period of ineligibility for her positive test, and because the sample was collected out-of-competition, there are no competitive results to disqualify.

• This media release was originally published by the US Anti-Doping Agency (USADA) on 6 November 2017. To access the original, please click here.

You may also like...

Pin It on Pinterest

Share This